Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
23,13 USD | +1,80% | +8,19% | -15,03% |
Métier
Nombre d'employés: 436
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Genetic Medicines
100,0
%
| 61 | 100,0 % | 378 | 100,0 % | +520,01% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 61 | 100,0 % | 378 | 100,0 % | +520,01% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
John Evans
CEO | Chief Executive Officer | 46 | 01/01/17 |
President | 55 | 01/02/18 | |
Director of Finance/CFO | 47 | 01/08/19 | |
Gopi Shanker
CTO | Chief Tech/Sci/R&D Officer | - | 21/03/23 |
Amy Simon
CTO | Chief Tech/Sci/R&D Officer | - | 15/03/21 |
Manmohan Singh
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/07/18 |
Brian Riley
PRN | Corporate Officer/Principal | 47 | 01/09/19 |
Susan O'Connor
HRO | Human Resources Officer | 61 | 01/08/17 |
Christine Bellon
LAW | General Counsel | - | 01/04/19 |
Suzanne Fleming
AUD | Comptroller/Controller/Auditor | 63 | 01/02/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Graham Cooper
BRD | Director/Board Member | 54 | 10/10/19 |
John Maraganore
BRD | Director/Board Member | 60 | 05/11/21 |
Mark Fishman
BRD | Director/Board Member | 72 | 01/05/18 |
Kristina Burow
BRD | Director/Board Member | 50 | 01/06/17 |
Director/Board Member | 68 | 10/01/21 | |
John Evans
CEO | Chief Executive Officer | 46 | 01/01/17 |
Christi L. Shaw
BRD | Director/Board Member | 57 | 14/12 |
Carole Ho
BRD | Director/Board Member | 51 | 15/11/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 82 310 167 | 80 795 167 ( 98,16 %) | 0 | 98,16 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
PRIME MEDICINE, INC. 1,34% | 1 608 337 | 1,34% | 11 258 359 $ |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-15,03% | 1,8 Md | |
+25,69% | 48,09 Md | |
+46,90% | 40,62 Md | |
-3,46% | 40,43 Md | |
-6,20% | 28,36 Md | |
+9,17% | 24,89 Md | |
-20,42% | 19,01 Md | |
+28,07% | 12,09 Md | |
+0,17% | 11,88 Md | |
-1,24% | 11,8 Md |
- Bourse
- Actions
- Action BEAM
- Société Beam Therapeutics Inc.